Long-term remission of an EBV-positive B cell lymphoproliferative disorder associated with rheumatoid arthritis under methotrexate with anti-CD20 monoclonal antibody (Rituximab) monotherapy
Open Access
- 2 October 2002
- journal article
- other
- Published by Springer Nature in Leukemia
- Vol. 16 (10) , 2173-2174
- https://doi.org/10.1038/sj.leu.2402588
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases.Journal of Clinical Oncology, 1996
- Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: Frequency of Epstein-Barr virus and other features associated with immunosuppressionHuman Pathology, 1994
- Reversible Lymphomas Associated with Epstein-Barr Virus Occurring during Methotrexate Therapy for Rheumatoid Arthritis and DermatomyositisNew England Journal of Medicine, 1993
- Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatmentThe American Journal of Medicine, 1985
- Defective EBV-Specific Suppressor T-Cell Function in Rheumatoid ArthritisNew England Journal of Medicine, 1981